Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging Ltd reported a quarterly revenue increase to $3.4 million, reflecting improved margins and greater utilization of its teleradiology services. The company's strategic partnership with Imperial Imaging Technology aims to enhance the deployment of its Nanox.ARC system across six Southeastern states, aligning with its goal to improve access to point-of-care imaging. Additionally, the recent FDA 510(k) clearance for the TAP2D cloud-enabled image enhancement capability is poised to enhance the Nanox.ARC's diagnostic capabilities, further solidifying management's confidence in achieving their 2026 revenue guidance of $35 million and supporting overall business expansion.

Bears say

Nano X Imaging Ltd has reported a significant decrease in cash reserves, totaling $55.5 million, down from $83.2 million at the year's end, indicating a troubling cash burn of $30.4 million and usage of the at-the-market (ATM) financing. The company has maintained a GAAP gross loss of $2.9 million and a stable net loss of $13.7 million, suggesting that despite investments in system deployments and AI infrastructure, profitability remains elusive. Additionally, the prolonged development and regulatory timelines, coupled with increased investment requirements beyond original expectations, contribute to a negative outlook for the company's future financial performance.

Nano-X Imaging (NNOX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 2 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Mar 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.